Erratum to: ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber Density
Albert Dahan(Centre for Human Drug Research), Michael Brines(Northwell Health), Anthony Cerami(Araim Pharmaceuticals (United States)), Monique van Velzen(Leiden University Medical Center), Paolo Proto(Leiden University Medical Center), Elise Sarton, Marieke Niesters(Leiden University Medical Center), Maarten Swartjes(Leiden University Medical Center), Ann Dunne(Araim Pharmaceuticals (United States)), Martijn R. Tannemaat(Leiden University Medical Center), O.J.M. Vogels(St. Antonius Ziekenhuis), Lara R. Heij(Maastricht University)
Cited by 0
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Pan-cancer image-based detection of clinically actionable genetic alterations
|Nature Cancer|2020|674